Kaneko M, Kumashiro H, Takahashi Y, Hoshino Y
Neuropsychobiology. 1979;5(4):232-40. doi: 10.1159/000117687.
Based on 5-HT hypothesis, L-5-HTP (150 or 300 mg/day) was given orally to 18 depressed patients. The global estimates were 2 very much improved; 8 much improved; 3 minimally improved, and 5 unchanged. The action of L-5-HTP was usually rapid. The elevation of the serum 5-HT level 1 week after L-5-HTP administration was relatively lower in the 5-HTP nonresponder group, compared with the responders. The chronological change of the serum 5-HT level in depressed patients after an oral loading dose of 3 mg/kg of L-5-HTP showed a gradual and slight elevation, compared with manic and normal groups. It seemed that the therapeutic effect of L-5-HTP on responders was related to lower 5-HT level in the brain for their pathogenesis, and that there was a metabolic disturbance of L-5-HTP into 5-HT in some depressed patients.
基于5-羟色胺假说,对18例抑郁症患者口服给予L-5-羟色氨酸(150或300毫克/天)。总体评估结果为:2例显著改善;8例明显改善;3例稍有改善;5例无变化。L-5-羟色氨酸的作用通常起效迅速。与有反应者相比,L-5-羟色氨酸给药1周后,5-羟色胺无反应者组血清5-羟色胺水平升高相对较低。口服3毫克/千克L-5-羟色氨酸负荷剂量后,抑郁症患者血清5-羟色胺水平的时间变化与躁狂症患者和正常组相比,呈逐渐轻微升高。L-5-羟色氨酸对有反应者的治疗效果似乎与其发病机制中大脑中较低的5-羟色胺水平有关,并且在一些抑郁症患者中存在L-5-羟色氨酸向5-羟色胺的代谢紊乱。